Technology Partners

Technology Partners is a venture capital and private equity firm specializing in incubation, seed/startup, early venture, mid venture, late venture, growth capital, PIPEs, and bridge investments. It seeks to invest in cleantech and life sciences sector. Within the cleantech sector, the firm prefers to invest in energy technology, water technology, and advanced materials. In the life sciences sector, it seeks to invest in consumer medicine, cost-effective medicine, and neurotechnology. It initially invests between $1 million and $15 million with total investment of up to $30 million per company. The firm prefers to be a lead investor and business advisor to its portfolio companies. Technology Partners was founded in 1980 and is based in Mill Valley, California with an additional office in Palo Alto, California.

Ted Ardell

Partner

Marc van den Berg

General Partner

JW

James W. Glasheen

General Partner

Jim Glasheen

General Partner

Sheila Mutter

General Partner and CFO

Roger Quy

General Partner

83 past transactions

Nfocus Neuromedical

Series B in 2007
Nfocus Neuromedical, Inc. designs, develops, and markets endovascular neurosurgery solutions to cure intracranial aneurysms. The company offers revolutionary systems to treat neurovascular disease, including brain aneurysms. The company was formerly known as CardioVasc, Inc. and changed its name to Nfocus Neuromedical, Inc. in April 2007. The company was incorporated in 1997 and is based in Palo Alto, California. As of February 19, 2013, Nfocus Neuromedical, Inc. operates as a subsidiary of Covidien plc.

ITM Software

Series B in 2003
ITM Software delivers the only truly integrated approach to IT Business Management - one solution and one system of record for comprehensive visibility, coordination and control across IT functions. Serving as the glue connecting the traditional silos of IT information, ITM enables increased transparency, better decisions, more effective spending, and improved business alignment. The company has a single focus on serving the business management needs of IT organizations. Lead by former CIOs and IT leaders, ITM Software brings a unique perspective to the management challenges facing IT today. This experience base, combined with a world-class software development team, translates into products and best-practice expertise that bring a business-centric approach to managing IT. At the core of the ITM offering is the ITM Business Suite, an integrated solution comprised of six components addressing the most critical areas of IT Business Management including people, processes, vendors, assets, financials, projects, and regulatory compliance. Coupled with the ITM Business Suite, the company provides best practice expertise and a proven methodology for helping clients define business objectives and develop and execute on a plan to achieve them. This unique combination of software products and management expertise enables CIOs to drive down IT costs, and increase the bottom line through improved alignment with the business objectives of the enterprise. Founded in 2001 by former CIOs, the Company serves IT organizations within Fortune 2000 corporations, government agencies and universities. ITM Software is privately held and is headquartered in Mountain View, California.

PowerGenix

Funding Round in 2008
PowerGenix develops and manufactures nickel-zinc rechargeable batteries and chargers for power-intensive electronics, toys, power tools, and hybrid electric vehicles. The company’s products are used in cordless power tools, UPS systems, electric scooters, specialty military equipment, and high-intensity DC lighting; military starting, lighting, and ignition vehicles; silent watches; equipment actuation; hybrid-electric propulsion systems; and consumer electronic devices and batteries. It supplies its products to original equipment manufacturers globally. PowerGenix was founded in 2000 and is headquartered in San Diego, California, United States with an additional manufacturing facility in Shenzhen, China.

PolyFuel

Series B in 2002
PolyFuel, Inc. designs, develops, engineers, and manufactures portable fuel cells to create electronic-based devices and products. The company was incorporated in 1999 and is headquartered in Mountain View, California.

Saegis Pharmaceuticals

Series B in 2003
Saegis Pharmaceuticals is focused on the development of medicines that address behavioral disorders. The company has a pipeline of treatments for central nervous system diseases involving cognitive dysfunction, including Alzheimer’s disease, mild cognitive impairment, attention deficit hyperactivity disorder, and cognitive impairment associated with schizophrenia. It develops CNS therapeutics for patients facing memory loss and cognition deficits associated with aging, psychiatric disorders, and brain trauma. Saegis Pharmaceuticals was founded in 1999 and is based in Half Moon Bay, California.

Spinal Dynamics

Series A in 1997
Spinal Dynamics develops neuro-surgical devices for the replacement of spinal disks. The company's Bryan Cervical Disc System is an implanted prosthesis designed to replace and mimic the flexibility and shock-absorbing characteristics of natural intervertebral discs. It features a shock-absorbing elastomer that is intended to cushion the vertebrae and allow movement of the head and neck and is designed to replace the disc that is removed from the patient in cervical spine surgery.

Incline Therapeutics

Series A in 2010
Incline Therapeutics is a privately-held, hospital-focused specialty pharmaceutical company focused on the development of IONSYS (fentanyl iontophoretic transdermal system). Incline is financed by leading life science venture capital firms and led by a management team with significant pharmaceutical and medical device industry experience.

Transcend Medical, Inc.

Series B in 2012
Transcend Medical, Inc., an ophthalmic device company, engages in the development of medical devices for the treatment of glaucoma. The company offers CyPass Micro-Stent, a micro-invasive tent that is inserted in the eye during routine cataract surgery; Vold Gonio Lens for use in micro-invasive glaucoma surgery. It also provides clinical trial services. Transcend Medical, Inc. was formerly known as iART Newco I, Inc. The company was founded in 2005 and is based in Menlo Park, California. As of March 23, 2016, Transcend Medical, Inc. operates as a subsidiary of Alcon Holdings, Inc.
Revance Therapeutics, Inc., a biopharmaceutical company, engages in developing and commercializing products and treatments in dermatology and aesthetic medicines. Its products include RT001, a physician-applied topical botulinum toxin type A (BoNT-A) for cosmetic, hyperhidrosis, and dermatologic indications. The company was formerly known as Essentia Biosystems, Inc. Revance Therapeutics, Inc. was founded in 2002 and is based in Mountain View, California.

Accelergy

Series B in 2006
Accelergy is a global leader in producing a direct replacement, low carbon, synthetic distillate liquids, and transportation fuels at a lower cost to both the environment and to the consumer. Accelergy uses domestic, carbon-based resources such as natural gas and biomass to produce cost-competitive liquids with a reduced CO2 footprint compared to traditional petroleum-based products. They do this without the expensive infrastructure required by many other alternative synthetics technologies. The company was founded in 2003 and headquartered in Houston, Texas.

ForSight Labs, LLC

Series C in 2014
ForSight Labs is focused on developing and applying solutions to improve the sight, care, and quality of life of visually impaired patients. Our environment is creative and collaborative; a place where entrepreneurs and investors work together to drive innovative technologies through concept, development, and ultimately commercialization in high-impact eye care companies (ForSight VISION companies). Each day millions of people rely on their vision and suffer when it is lost. There are few disabilities as impactful to quality of life as the loss of vision. The number of people with impaired vision in the US, including blindness, is expected to more than double over the next three decades. Recent estimates of the cost of vision loss in the US exceed $50 billion dollars annually. ForSight Labs brings together highly motivated and capable team members, clinicians and investors focused on starting and sustaining efforts to deliver innovative solutions to the ophthalmic community and the patients it serves.

PolyFuel

Series C in 2004
PolyFuel, Inc. designs, develops, engineers, and manufactures portable fuel cells to create electronic-based devices and products. The company was incorporated in 1999 and is headquartered in Mountain View, California.

Rinat Neuroscience

Series A in 2001
Rinat, which means "happiness" in Hebrew, was formed in 2001 when Genentech, a leader in the development of therapeutic antibodies, narrowed its focus and spun out its key neuroscience assets under a broad license to Rinat. Genentech invested significant R&D resources in support of these assets over 15 years, and Rinat is now building on them as the pioneer in developing and commercializing antibody drugs for the treatment of diseases and disorders of the nervous system.

Medley Health

Series A in 2011
Medley Health is an innovative, entrepreneurial, technology-driven company. It's backed by top-tier investors and a management team with deep business expertise in healthcare, Internet and web services, as well as next-generation communications technologies.

Spinal Dynamics

Series B in 2001
Spinal Dynamics develops neuro-surgical devices for the replacement of spinal disks. The company's Bryan Cervical Disc System is an implanted prosthesis designed to replace and mimic the flexibility and shock-absorbing characteristics of natural intervertebral discs. It features a shock-absorbing elastomer that is intended to cushion the vertebrae and allow movement of the head and neck and is designed to replace the disc that is removed from the patient in cervical spine surgery.
Revance Therapeutics, Inc., a biopharmaceutical company, engages in developing and commercializing products and treatments in dermatology and aesthetic medicines. Its products include RT001, a physician-applied topical botulinum toxin type A (BoNT-A) for cosmetic, hyperhidrosis, and dermatologic indications. The company was formerly known as Essentia Biosystems, Inc. Revance Therapeutics, Inc. was founded in 2002 and is based in Mountain View, California.

Storability Software

Series D in 2003
Storability Software is a provider of enterprise storage resource management solutions that simplify and centralize the management of complex, multi-site, multi-vendor storage infrastructures. Storability Software's Global Storage Manager is an open standards-based solution that enables customers to comprehend, control, and capitalize on their storage investment as never before. Customers benefit from increased asset utilization, improved management efficiency, enhanced quality of service, and higher availability.

PowerGenix

Series C in 2006
PowerGenix develops and manufactures nickel-zinc rechargeable batteries and chargers for power-intensive electronics, toys, power tools, and hybrid electric vehicles. The company’s products are used in cordless power tools, UPS systems, electric scooters, specialty military equipment, and high-intensity DC lighting; military starting, lighting, and ignition vehicles; silent watches; equipment actuation; hybrid-electric propulsion systems; and consumer electronic devices and batteries. It supplies its products to original equipment manufacturers globally. PowerGenix was founded in 2000 and is headquartered in San Diego, California, United States with an additional manufacturing facility in Shenzhen, China.

Iomai Corporation

Series C in 2003
Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called transcutaneous immunization (TCI). TCI taps into the unique benefits of a major group of antigen-presenting cells found in the outer layers of the skin to generate an enhanced immune response. Iomai is leveraging TCI to enhance the efficacy of existing vaccines, enable new vaccines that are viable only through transcutaneous administration and expand the global vaccine market. The company was incorporated in 1997 and is based in Gaithersburg, Maryland. Intercell USA, Inc. was formerly known as Iomai Corporation. As a result of the acquisition of Iomai Corporation by Intercell Ag, Iomai Corporation's name was changed. As of August 5, 2008, Intercell USA, Inc. operates as a subsidiary of Intercell Biomedical Research & Development AG.

Akros Silicon

Venture Round in 2012
Akros Silicon is a semiconductor company developing power management ICs that facilitate remote network-based energy management. The company offers intelligent energy management ICs that enable the implementation of global green power management initiatives. Its products include integrated CMOS solutions, electro-magnetic interference (EMI) and electro-static discharge suppressors, and dual-channel active EMI suppressors. The company's products are used in voice over IP phones, wireless LAN access point, analog telephone adapters, RFID and point of sales terminals, IP video security cameras, set-top boxes, networked printers and appliances, desktop and laptop computers, and PoE and non-PoE Ethernet systems applications. The company offers its products through sales representatives in the United States, Canada, the Peoples Republic of China, Taiwan, Korea, Turkey, Austria, Belgium, Germany, the Czech Republic, Italy, Germany, Poland, Portugal, Spain, Switzerland, the Netherlands, the United Kingdom, and Ireland. It was founded in 2005 and is based in Folsom, California.
Revance Therapeutics, Inc., a biopharmaceutical company, engages in developing and commercializing products and treatments in dermatology and aesthetic medicines. Its products include RT001, a physician-applied topical botulinum toxin type A (BoNT-A) for cosmetic, hyperhidrosis, and dermatologic indications. The company was formerly known as Essentia Biosystems, Inc. Revance Therapeutics, Inc. was founded in 2002 and is based in Mountain View, California.

Tesla, Inc.

Series D in 2007
Tesla, Inc. designs, develops, manufactures, leases, and sells electric vehicles, and energy generation and storage systems in the United States, China, Netherlands, Norway, and internationally. The company operates in two segments, Automotive; and Energy Generation and Storage. The Automotive segment offers sedans and sport utility vehicles. It also provides electric powertrain components and systems; and services for electric vehicles through its company-owned service locations, and Tesla mobile service technicians, as well as sells used vehicles. This segment markets and sells its products through a network of company-owned stores and galleries, as well as through its own Website. The Energy Generation and Storage segment offers energy storage products, such as rechargeable lithium-ion battery systems for use in homes, industrial, commercial facilities, and utility grids; and designs, manufactures, installs, maintains, leases, and sells solar energy generation and energy storage products to residential and commercial customers. It also provides vehicle insurance services, as well as renewable energy. The company was formerly known as Tesla Motors, Inc. and changed its name to Tesla, Inc. in February 2017. Tesla, Inc. was founded in 2003 and is headquartered in Palo Alto, California.

Transcend Medical, Inc.

Series B in 2011
Transcend Medical, Inc., an ophthalmic device company, engages in the development of medical devices for the treatment of glaucoma. The company offers CyPass Micro-Stent, a micro-invasive tent that is inserted in the eye during routine cataract surgery; Vold Gonio Lens for use in micro-invasive glaucoma surgery. It also provides clinical trial services. Transcend Medical, Inc. was formerly known as iART Newco I, Inc. The company was founded in 2005 and is based in Menlo Park, California. As of March 23, 2016, Transcend Medical, Inc. operates as a subsidiary of Alcon Holdings, Inc.

Accelergy

Series A in 2004
Accelergy is a global leader in producing a direct replacement, low carbon, synthetic distillate liquids, and transportation fuels at a lower cost to both the environment and to the consumer. Accelergy uses domestic, carbon-based resources such as natural gas and biomass to produce cost-competitive liquids with a reduced CO2 footprint compared to traditional petroleum-based products. They do this without the expensive infrastructure required by many other alternative synthetics technologies. The company was founded in 2003 and headquartered in Houston, Texas.
Tonix Pharmaceuticals Holding Corp., a development stage specialty pharmaceutical company, focuses on the development of pharmaceutical products for the disorders of central nervous system. The company’s lead product candidate includes TNX-102 SL, a dose and formulation of cyclobenzaprine for the treatment of fibromyalgia and post-traumatic stress disorder. It also has a pipeline of various other product candidates, including TNX-201, which is a treatment for certain types of headaches; and TNX-301. The company was founded in 2007 and is headquartered in New York, New York.

Imperium Renewables

Series B in 2007
Imperium Renewables, Inc., together with its subsidiary, produces and markets biodiesel in the United States. The company produces biodiesel from feedstock oils; and glycerin, a by-product of biodiesel. Its biodiesel is used as alternative fuel in cars, trucks, ships, trains, and planes. The company markets its products through a network of distributors. Imperium Renewables, Inc. was formerly known as Seattle Biodiesel, LLC and changed its name to Imperium Renewables, Inc. in May 2005. The company was founded in 2004 and is based in Seattle, Washington. It has production facilities in Hoquiam, Washington; and Oahu, Hawaii.

HeartStent

Venture Round in 1999
HeartStent is a cardiovascular device firm. It is a direct revascularization device intended for coronary artery disease patients currently treated with coronary artery bypass grafts.

Benvenue Medical

Series D in 2012
Benvenue Medical, Inc. is developing innovative, minimally invasive surgical solutions to treat spinal disorders. The company is privately held and funded by CRG Partners.

Visiogen

Series D in 2009
Visiogen, Inc. is an ophthalmic medical device company specializing in the development of new vision alternatives for patients with cataracts, with and without presbyopia. As part of this mission, Visiogen created the Synchrony dual optic accommodating *intraocular lens (IOL)* for use in the surgical treatment of these conditions. The device is designed to provide patients with near, intermediate and distance vision in a seamless continuum without the need for glasses or contact lenses. To eliminate lens handling during surgery, the Synchrony dual optic IOL is provided in a pre-loaded injector. This patented technology has been approved in Europe with a CE Mark designation and is currently undergoing clinical trials in the United States.

Elcelyx Therapeutics

Series B in 2012
Elcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx’s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets. Elcelyx is headquartered in San Diego, California.

Rinat Neuroscience

Series B in 2003
Rinat, which means "happiness" in Hebrew, was formed in 2001 when Genentech, a leader in the development of therapeutic antibodies, narrowed its focus and spun out its key neuroscience assets under a broad license to Rinat. Genentech invested significant R&D resources in support of these assets over 15 years, and Rinat is now building on them as the pioneer in developing and commercializing antibody drugs for the treatment of diseases and disorders of the nervous system.

Beamreach

Series C in 2013
Beamreach Solar is developing high-efficiency, low-cost, crystalline silicon solar cells and modules for photovoltaic (PV) electricity generation.

Encirq Corporation

Venture Round in 2000
Encirq solves marketing's #1 challenge: Delivering Personalization with Privacy™. Encirq is an online marketing services company that has developed a unique data engine to deliver individualized, consumer-centered marketing over the Internet. We use online and offline, real-time individual transactional data in a private and secure environment. Marketers and Encirq cannot see the data. Rather, the data reside on each consumer's personal computer, and filter out marketing messages that are not relevant. The service and technology are extendible to broadband, to other network devices, and eventually can be used to deliver personalized television commercials to individual households. Encirq's data engine does two things: It provides cost-effective access to consumer information not previously available; and it enables personalized real-time marketing programs. We have filed multiple patent applications on Encirq's illumination processes and technology.

ForSight Labs, LLC

Series B in 2013
ForSight Labs is focused on developing and applying solutions to improve the sight, care, and quality of life of visually impaired patients. Our environment is creative and collaborative; a place where entrepreneurs and investors work together to drive innovative technologies through concept, development, and ultimately commercialization in high-impact eye care companies (ForSight VISION companies). Each day millions of people rely on their vision and suffer when it is lost. There are few disabilities as impactful to quality of life as the loss of vision. The number of people with impaired vision in the US, including blindness, is expected to more than double over the next three decades. Recent estimates of the cost of vision loss in the US exceed $50 billion dollars annually. ForSight Labs brings together highly motivated and capable team members, clinicians and investors focused on starting and sustaining efforts to deliver innovative solutions to the ophthalmic community and the patients it serves.

Beamreach

Series D in 2015
Beamreach Solar is developing high-efficiency, low-cost, crystalline silicon solar cells and modules for photovoltaic (PV) electricity generation.

NeuroPace

Venture Round in 2005
NeuroPace, Inc. designs, develops, manufactures, and markets implantable devices for the treatment of neurological disorders with responsive stimulation. It offers RNS System, a medical device that monitors and responds to brain activity. The company’s RNS System consists of a small implantable neuro stimulator that is connected to leads that are placed in up to two seizure onset areas. NeuroPace, Inc. was founded in 1997 and is based in Mountain View, California.

Leptos Biomedical

Series C in 2007
Leptos Biomedical offers a proprietary neuromodulation therapy solution for chronic obesity. The company delivers its treatment, which involves the electrical activation of a nerve in the autonomic nervous system via a pacemaker-type device. Leptos Biomedical was founded in 2002 and is based in Fridley, Minnesota.

E-LOAN

Post in 2000
E-LOAN is a nationwide financial services company that is dedicated to providing consumers with a simple, easy and open way to obtain high yield savings accounts and CDs. Their web site also provides access to several preferred, nationally recognized lending partners that may be able to assist you in obtaining a loan that meets your financial needs. Since its launch in 1997, E-LOAN has drawn upon its pro consumer values to deliver their customers the best online experience possible.

TRIA Beauty, Inc.

Venture Round in 2012
TRIA Beauty, Inc. develops and markets light-based therapeutic beauty systems for the consumer market. The company provides a diode laser hair removal system for home use. It offers its products through a network of retailers in California, Florida, Illinois, Louisiana, Minnesota, Nevada, New Jersey, New York, Pennsylvania, Tennessee, Texas, Utah, Virginia, and Washington. TRIA Beauty, Inc. was formerly known as SpectraGenics, Inc. and changed its name to TRIA Beauty, Inc. in July 2008. The company was founded in 2003 and is based in Pleasanton, California.

APX, Inc.

Series C in 2000
APX has continuously provided innovative technology and service solutions for the energy and environmental markets. Their business experience spans transaction management, registries, scheduling, settlements, demand-side management, asset control, analytics, operations, exchanges, clearing, and brokerage. They continue to leverage their deep domain and technological expertise, providing focused solutions for their clients in the energy and environmental markets. This depth and breadth of knowledge makes the APX team uniquely qualified to provide leading-edge market solutions that deliver trust, integrity, and experience.

Kaiam

Venture Round in 2013
Kaiam is a private company commercializing photonic integrated circuits. In plain language, they specialize in the design and manufacture of gadgets that help transmit and receive data at very high speeds. The company also manufactures optronics equipment for computer networking and hyper-scale data centers. It also uses micromachined silicon, a demonstrated the CWDM4, a 100 Gigabit-per-second coarse wavelength division multiplexing (CWDM) silicon photonics transceiver using silicon modules and receivers.

Sensicore

Series B in 2003
Sensicore, Inc. develops smart sensor systems and sensor networks that automate water testing, data collection, and analysis for drinking and industrial applications. It offers WaterPOINT, a handheld screening tool and water tester that provides a profile of various chemistry measurements, allowing users to conduct various tests at sites, as well as allows municipalities to manage resources; and WaterNOW, a Web-based data visualization, analysis, and decision support system that enable users to manage water system and data collected by WaterPOINT and other sources. The company also provides sensor kits and bundles, which include disinfection and disinfection/DPD chlorine drinking water test kits, and basic water test kits; and colorimetric test kits, including aluminum, bromine, chloride, copper, cyanide, fluoride, iron, manganese, molybdate, nitrate, nitrite, ortho-phosphate, silica, sulfate, sulfide, and zinc vacuum ampoules. In addition, the company offers accessories, such as portable thermal printers, communications cables, power inverters, and power supply products. It offers products for measuring and monitoring water quality, including incoming water quality and boiler feed monitoring; cooling tower monitoring and process control; filtration system performance monitoring; cleaning and rinse control system monitoring; product testing and control; and food and beverage applications. The company was founded in 2000 and is based in Ann Arbor, Michigan. As of March 31, 2008, Sensicore, Inc. operates as a subsidiary of GE Analytical Instruments, Inc.

BrainCells

Series B in 2008
BrainCells develops and provides biopharmaceutical products for the treatment of central nervous system (CNS) diseases. It develops compounds that promote the growth of new neurons for the treatment of major depressive disorder (MDD), treatment resistant depression (TRD), and potentially Alzheimer’s disease (AD). The company's products include BCI-838 and BCI-632 which increase synaptic glutamate by inhibiting the mGlu2/3 auto-receptor. The company also builds a pipeline of clinical-stage programs to address unmet medical needs in the treatment of mood disorders, psychoses, cognition, brain repair syndromes, and other CNS disorders. The company was founded in 2003 and is based in San Diego, California.

Alta Devices

Private Equity Round in 2011
Alta Devices, Inc. manufactures single junction solar technology. It offers thin and flexible mobile power technology for use in unmanned systems, consumer electronics, sensors, automotive, remote exploration/power, wearables, and Internet of things applications. Alta Devices, Inc. was formerly known as Hanergy Acquisition Sub Inc. The company was founded in 2007 and is based in Sunnyvale, California. As of February 15, 2015, Alta Devices, Inc. operates as a subsidiary of Hanergy Hi-Tech Power (HK) Limited.

Beamreach

Series C in 2012
Beamreach Solar is developing high-efficiency, low-cost, crystalline silicon solar cells and modules for photovoltaic (PV) electricity generation.

ForSight VISION5

Series C in 2014
ForSight VISION5 was founded in 2010 as the fifth company created by the ophthalmic product incubator, ForSight Labs. ForSight VISION5 is developing non-invasive products that replace eye drops and provide sustained therapy for major eye diseases including glaucoma, dry eye, and allergy. The company is currently in its second Phase 2 clinical study for its lead product, the Helios insert.

ITM Software

Venture Round in 2005
ITM Software delivers the only truly integrated approach to IT Business Management - one solution and one system of record for comprehensive visibility, coordination and control across IT functions. Serving as the glue connecting the traditional silos of IT information, ITM enables increased transparency, better decisions, more effective spending, and improved business alignment. The company has a single focus on serving the business management needs of IT organizations. Lead by former CIOs and IT leaders, ITM Software brings a unique perspective to the management challenges facing IT today. This experience base, combined with a world-class software development team, translates into products and best-practice expertise that bring a business-centric approach to managing IT. At the core of the ITM offering is the ITM Business Suite, an integrated solution comprised of six components addressing the most critical areas of IT Business Management including people, processes, vendors, assets, financials, projects, and regulatory compliance. Coupled with the ITM Business Suite, the company provides best practice expertise and a proven methodology for helping clients define business objectives and develop and execute on a plan to achieve them. This unique combination of software products and management expertise enables CIOs to drive down IT costs, and increase the bottom line through improved alignment with the business objectives of the enterprise. Founded in 2001 by former CIOs, the Company serves IT organizations within Fortune 2000 corporations, government agencies and universities. ITM Software is privately held and is headquartered in Mountain View, California.

Benvenue Medical

Series C in 2011
Benvenue Medical, Inc. is developing innovative, minimally invasive surgical solutions to treat spinal disorders. The company is privately held and funded by CRG Partners.

Beamreach

Series B in 2008
Beamreach Solar is developing high-efficiency, low-cost, crystalline silicon solar cells and modules for photovoltaic (PV) electricity generation.

CoalTek, Inc.

Convertible Note in 2013
CoalTek's technology reduces moisture content in a broad range of coals, optimizing plant efficiency and delivering environmental integrity. The CoalTek process was developed, tested, and proven over eight years by Dr. Jerry Weinberg, the company's co-founder, along with chief geologist Neil Ginther. CoalTek opened its first commercial processing facility in Calvert City, Kentucky in 2006. The plant's initial capacity of 120,000 tons/yr will be expanded in the future, and there are also plans to build additional facilities, to meet the growing demand for clean coal.

TRIA Beauty, Inc.

Series D in 2007
TRIA Beauty, Inc. develops and markets light-based therapeutic beauty systems for the consumer market. The company provides a diode laser hair removal system for home use. It offers its products through a network of retailers in California, Florida, Illinois, Louisiana, Minnesota, Nevada, New Jersey, New York, Pennsylvania, Tennessee, Texas, Utah, Virginia, and Washington. TRIA Beauty, Inc. was formerly known as SpectraGenics, Inc. and changed its name to TRIA Beauty, Inc. in July 2008. The company was founded in 2003 and is based in Pleasanton, California.

TRIA Beauty, Inc.

Venture Round in 2011
TRIA Beauty, Inc. develops and markets light-based therapeutic beauty systems for the consumer market. The company provides a diode laser hair removal system for home use. It offers its products through a network of retailers in California, Florida, Illinois, Louisiana, Minnesota, Nevada, New Jersey, New York, Pennsylvania, Tennessee, Texas, Utah, Virginia, and Washington. TRIA Beauty, Inc. was formerly known as SpectraGenics, Inc. and changed its name to TRIA Beauty, Inc. in July 2008. The company was founded in 2003 and is based in Pleasanton, California.

Imagicast

Series C in 2000
Imagicast, Inc. provides strategic merchandising solutions for retailers.

Beamreach

Series D in 2014
Beamreach Solar is developing high-efficiency, low-cost, crystalline silicon solar cells and modules for photovoltaic (PV) electricity generation.

Benvenue Medical

Series F in 2016
Benvenue Medical, Inc. is developing innovative, minimally invasive surgical solutions to treat spinal disorders. The company is privately held and funded by CRG Partners.
Revance Therapeutics, Inc., a biopharmaceutical company, engages in developing and commercializing products and treatments in dermatology and aesthetic medicines. Its products include RT001, a physician-applied topical botulinum toxin type A (BoNT-A) for cosmetic, hyperhidrosis, and dermatologic indications. The company was formerly known as Essentia Biosystems, Inc. Revance Therapeutics, Inc. was founded in 2002 and is based in Mountain View, California.

EmSense

Series C in 2009
EmSense Corporation provides scalable physiological and brainwave measurement technology. Its EmSense headset measures brainwave cognition and emotion on a moment by moment basis as consumers are exposed to advertising, video games, political messaging, movies, and TV shows, as well as incorporates physiological sensors that measure viewers' blinking, breathing, and physical motion to their heart activity and moments when they blush. The company was founded in 2004 and is based in San Francisco, California with additional offices in Monterey and Santa Monica, California.

Elcelyx Therapeutics

Series C in 2014
Elcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx’s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets. Elcelyx is headquartered in San Diego, California.

AllAdvantage

Venture Round in 2000
As of January 2001, AllAdvantage Inc. went out of business. AllAdvantage.com, Inc. operates as an Internet advertising company. It pays its users/members a portion of the advertising revenue generated by their online viewing habits. The company also allows members to receive membership benefits that include sponsor discounts and rebates for surfing the Web. In addition, it provides incentives for advertisers to build one-on-one relationships with its members. The company was founded in 1999 and is based in Hayward, California with additional offices in Atlanta, Boston, Chicago, Dallas, Detroit, Hayward, London, Los Angeles, New York, Paris, Seattle, Sydney, and Washington DC.

APX, Inc.

Series C in 2000
APX has continuously provided innovative technology and service solutions for the energy and environmental markets. Their business experience spans transaction management, registries, scheduling, settlements, demand-side management, asset control, analytics, operations, exchanges, clearing, and brokerage. They continue to leverage their deep domain and technological expertise, providing focused solutions for their clients in the energy and environmental markets. This depth and breadth of knowledge makes the APX team uniquely qualified to provide leading-edge market solutions that deliver trust, integrity, and experience.

ITM Software

Venture Round in 2007
ITM Software delivers the only truly integrated approach to IT Business Management - one solution and one system of record for comprehensive visibility, coordination and control across IT functions. Serving as the glue connecting the traditional silos of IT information, ITM enables increased transparency, better decisions, more effective spending, and improved business alignment. The company has a single focus on serving the business management needs of IT organizations. Lead by former CIOs and IT leaders, ITM Software brings a unique perspective to the management challenges facing IT today. This experience base, combined with a world-class software development team, translates into products and best-practice expertise that bring a business-centric approach to managing IT. At the core of the ITM offering is the ITM Business Suite, an integrated solution comprised of six components addressing the most critical areas of IT Business Management including people, processes, vendors, assets, financials, projects, and regulatory compliance. Coupled with the ITM Business Suite, the company provides best practice expertise and a proven methodology for helping clients define business objectives and develop and execute on a plan to achieve them. This unique combination of software products and management expertise enables CIOs to drive down IT costs, and increase the bottom line through improved alignment with the business objectives of the enterprise. Founded in 2001 by former CIOs, the Company serves IT organizations within Fortune 2000 corporations, government agencies and universities. ITM Software is privately held and is headquartered in Mountain View, California.

Abound Solar

Venture Round in 2008
Abound Solar produces next-generation, thin film photovoltaic modules intended to deliver the lowest levelized cost of electricity.

Storability Software

Series C in 2002
Storability Software is a provider of enterprise storage resource management solutions that simplify and centralize the management of complex, multi-site, multi-vendor storage infrastructures. Storability Software's Global Storage Manager is an open standards-based solution that enables customers to comprehend, control, and capitalize on their storage investment as never before. Customers benefit from increased asset utilization, improved management efficiency, enhanced quality of service, and higher availability.

ForSight VISION5

Series B in 2013
ForSight VISION5 was founded in 2010 as the fifth company created by the ophthalmic product incubator, ForSight Labs. ForSight VISION5 is developing non-invasive products that replace eye drops and provide sustained therapy for major eye diseases including glaucoma, dry eye, and allergy. The company is currently in its second Phase 2 clinical study for its lead product, the Helios insert.

NanoGram

Venture Round in 2006
NanoGram Corporation develops and manufactures products for the next generation of photovoltaics, electronics and displays. A dynamic and agile nanotechnology company, NanoGram has incubated and spun out two successful companies in NeoPhotonics and NanoGram Devices. The NanoGram KK office in Tokyo, and a strategic development and manufacturing supply relationship with Nagase & Co., Ltd / Nagase ChemteX Corporation, supports their growing presence in Japan, while the NanoGram Korea office in Seoul serves the expanding markets and opportunities in Korea.

Transcend Medical, Inc.

Series C in 2014
Transcend Medical, Inc., an ophthalmic device company, engages in the development of medical devices for the treatment of glaucoma. The company offers CyPass Micro-Stent, a micro-invasive tent that is inserted in the eye during routine cataract surgery; Vold Gonio Lens for use in micro-invasive glaucoma surgery. It also provides clinical trial services. Transcend Medical, Inc. was formerly known as iART Newco I, Inc. The company was founded in 2005 and is based in Menlo Park, California. As of March 23, 2016, Transcend Medical, Inc. operates as a subsidiary of Alcon Holdings, Inc.

Akros Silicon

Venture Round in 2012
Akros Silicon is a semiconductor company developing power management ICs that facilitate remote network-based energy management. The company offers intelligent energy management ICs that enable the implementation of global green power management initiatives. Its products include integrated CMOS solutions, electro-magnetic interference (EMI) and electro-static discharge suppressors, and dual-channel active EMI suppressors. The company's products are used in voice over IP phones, wireless LAN access point, analog telephone adapters, RFID and point of sales terminals, IP video security cameras, set-top boxes, networked printers and appliances, desktop and laptop computers, and PoE and non-PoE Ethernet systems applications. The company offers its products through sales representatives in the United States, Canada, the Peoples Republic of China, Taiwan, Korea, Turkey, Austria, Belgium, Germany, the Czech Republic, Italy, Germany, Poland, Portugal, Spain, Switzerland, the Netherlands, the United Kingdom, and Ireland. It was founded in 2005 and is based in Folsom, California.

Sensicore

Series C in 2005
Sensicore, Inc. develops smart sensor systems and sensor networks that automate water testing, data collection, and analysis for drinking and industrial applications. It offers WaterPOINT, a handheld screening tool and water tester that provides a profile of various chemistry measurements, allowing users to conduct various tests at sites, as well as allows municipalities to manage resources; and WaterNOW, a Web-based data visualization, analysis, and decision support system that enable users to manage water system and data collected by WaterPOINT and other sources. The company also provides sensor kits and bundles, which include disinfection and disinfection/DPD chlorine drinking water test kits, and basic water test kits; and colorimetric test kits, including aluminum, bromine, chloride, copper, cyanide, fluoride, iron, manganese, molybdate, nitrate, nitrite, ortho-phosphate, silica, sulfate, sulfide, and zinc vacuum ampoules. In addition, the company offers accessories, such as portable thermal printers, communications cables, power inverters, and power supply products. It offers products for measuring and monitoring water quality, including incoming water quality and boiler feed monitoring; cooling tower monitoring and process control; filtration system performance monitoring; cleaning and rinse control system monitoring; product testing and control; and food and beverage applications. The company was founded in 2000 and is based in Ann Arbor, Michigan. As of March 31, 2008, Sensicore, Inc. operates as a subsidiary of GE Analytical Instruments, Inc.

SkillsVillage

Series B in 2000
SkillsVillage.com provides a blended model of applications and services across the entire procurement lifecycle for finding, hiring, and managing contract workers - enabling companies to deploy workers quickly and efficiently, aggregate staffing suppliers, and optimize business processes.

Storability Software

Series B in 2001
Storability Software is a provider of enterprise storage resource management solutions that simplify and centralize the management of complex, multi-site, multi-vendor storage infrastructures. Storability Software's Global Storage Manager is an open standards-based solution that enables customers to comprehend, control, and capitalize on their storage investment as never before. Customers benefit from increased asset utilization, improved management efficiency, enhanced quality of service, and higher availability.

CoalTek, Inc.

Series B in 2006
CoalTek's technology reduces moisture content in a broad range of coals, optimizing plant efficiency and delivering environmental integrity. The CoalTek process was developed, tested, and proven over eight years by Dr. Jerry Weinberg, the company's co-founder, along with chief geologist Neil Ginther. CoalTek opened its first commercial processing facility in Calvert City, Kentucky in 2006. The plant's initial capacity of 120,000 tons/yr will be expanded in the future, and there are also plans to build additional facilities, to meet the growing demand for clean coal.

CoalTek, Inc.

Series A in 2005
CoalTek's technology reduces moisture content in a broad range of coals, optimizing plant efficiency and delivering environmental integrity. The CoalTek process was developed, tested, and proven over eight years by Dr. Jerry Weinberg, the company's co-founder, along with chief geologist Neil Ginther. CoalTek opened its first commercial processing facility in Calvert City, Kentucky in 2006. The plant's initial capacity of 120,000 tons/yr will be expanded in the future, and there are also plans to build additional facilities, to meet the growing demand for clean coal.

eNeura Therapeutics

Series B in 2005
ENeura Therapeutics is a medical technology company developing transcranial magnetic stimulation devices for the treatment of migraines. It pioneers the use of portable, non-invasive Transcranial Magnetic Stimulation (TMS) devices for the treatment of migraine. Prescribed by physicians but designed for patient use, it is the first truly portable, convenient TMS product that will allow migraine patients to administer treatment as needed—at home, in the office, or on the go.

Scioderm, LLC

Series A in 2013
Scioderm, LLC researches, develops, and manufactures drugs for the treatment of patients with epidermolysis bullosa (EB). It offers Zorblisa, an investigational therapy for the treatment of skin blistering and lesions associated with EB, a rare group of inherited disorders that manifest as blistering or erosion of the skin, and the epithelial lining of other organs. The company’s Zorblisa facilitates the healing of skin lesions and reduction of the incidence and/or severity of new lesions. The company was founded in 2012 and is based in Durham, North Carolina. As of September 30, 2015, Scioderm, LLC operates as a subsidiary of Amicus Therapeutics, Inc.

BioTrove

Venture Round in 2006
BioTrove, Inc. provides micro and nano-scale technology platforms for life science and drug discovery research applications. The company offers OpenArray, a technology platform for relative gene expression analysis that advances genomic research in various life science fields, including agriculture, disease research, and public health; RapidFire, a technology platform that enables the screening of intractable drug targets via mass spectrometry based assay development; and RapidFire mass spectrometry hardware system, a native detection technology for drug screening and in vitro ADME applications.

Datria Systems

Series C in 2002
Datria provides packaged mobility solutions that voice-enable existing/new business processes. Workers use their existing phones or VoIP-capable devices to exchange information in real-time with all corporate systems.

Benvenue Medical

Series E in 2014
Benvenue Medical, Inc. is developing innovative, minimally invasive surgical solutions to treat spinal disorders. The company is privately held and funded by CRG Partners.

eNeura Therapeutics

Series A in 2002
ENeura Therapeutics is a medical technology company developing transcranial magnetic stimulation devices for the treatment of migraines. It pioneers the use of portable, non-invasive Transcranial Magnetic Stimulation (TMS) devices for the treatment of migraine. Prescribed by physicians but designed for patient use, it is the first truly portable, convenient TMS product that will allow migraine patients to administer treatment as needed—at home, in the office, or on the go.

Kaiam

Venture Round in 2014
Kaiam is a private company commercializing photonic integrated circuits. In plain language, they specialize in the design and manufacture of gadgets that help transmit and receive data at very high speeds. The company also manufactures optronics equipment for computer networking and hyper-scale data centers. It also uses micromachined silicon, a demonstrated the CWDM4, a 100 Gigabit-per-second coarse wavelength division multiplexing (CWDM) silicon photonics transceiver using silicon modules and receivers.

Beamreach

Series C in 2012
Beamreach Solar is developing high-efficiency, low-cost, crystalline silicon solar cells and modules for photovoltaic (PV) electricity generation.

Transcend Medical, Inc.

Series B in 2009
Transcend Medical, Inc., an ophthalmic device company, engages in the development of medical devices for the treatment of glaucoma. The company offers CyPass Micro-Stent, a micro-invasive tent that is inserted in the eye during routine cataract surgery; Vold Gonio Lens for use in micro-invasive glaucoma surgery. It also provides clinical trial services. Transcend Medical, Inc. was formerly known as iART Newco I, Inc. The company was founded in 2005 and is based in Menlo Park, California. As of March 23, 2016, Transcend Medical, Inc. operates as a subsidiary of Alcon Holdings, Inc.

NightFire Software

Series D in 2002
NightFire Software offers the first packaged order management software to automate the telecommunications service supply chain. By simplifying the interaction between retailers and wholesalers of telecommunications services, NightFire's products enable telecommunications service providers to deliver services quickly and cost-effectively to the newly deregulated telecommunications market, estimated to be $160 billion in 1998. The NightFire flagship product, NetServ Express automates the entire ordering process for competitive service providers, ensuring the highest level of service at the lowest cost and reducing the management burden on incumbent providers.

Elcelyx Therapeutics

Series E in 2015
Elcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx’s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets. Elcelyx is headquartered in San Diego, California.